Merck has moved to coordinate dozens of lawsuits brought over injuries allegedly caused by its shingles vaccine, Zostavax.
In an April 20 motion, Michaela Roberts, an attorney for Merck & Co. and Merck Sharp & Dohme Corp., asked the U.S. Judicial Panel on Multidistrict Litigation to transfer 57 cases to U.S. District Senior Judge James Moody of the Middle District of Florida, or U.S. District Senior Judge Harvey Bartle of the Eastern District of Pennsylvania. The motion comes as Merck has 27 pending “substantively identical motions to dismiss” before 13 judges.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
